Summary of Classification and Labelling
Notified classification and labelling
General Information
280-426-3 |
4-(benzoylamino)-6-[[5-[[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]methyl]-1-sulpho-2-naphthyl]azo]-5-hydroxynaphthalene-1,7-disulphonic acid, lithium sodium salt |
83400-11-7 |
Notified classification and labelling according to CLP criteria
Skin Sens. 1B |
H317
|
H317
|
|
GHS08 GHS09 Dgr
|
M(Chronic)=1
|
|
|
|
1 |
|
View details
|
Resp. Sens. 1 |
H334
|
H334
|
Aquatic Chronic 2 |
H411
|
H411
|
Skin Sens. 1 |
H317
|
H317
|
|
GHS07 Wng
|
|
|
|
|
11 |
|
View details
|
Number of Aggregated Notifications: 2